Latest News

  • Diagnostics Funding for Infectious Diseases, Applied NGS: Follow the Money

    Diagnostics World News | NGS turnkey diagnostics, noninvasive prenatal testing with simplified sample collection, infection disease diagnostics, and more.

    Jun 3, 2021
  • New COVID Diagnostics, Pandemic Sciences Centre Launches, New Products

    Diagnostics World News | University of Oxford launches a new Pandemic Sciences Centre, Quest Diagnostics and Paige collaborate on AI for diagnostics, new products from Waters and Essenlix Corp, and COVID updates from Advanced Biological Laboratories, Ortho Clinical Diagnostics, Thermo Fisher.

    Jun 1, 2021
  • Synthetic Data Helps AI Train To Classify Brain Tumors

    Diagnostics World News | Over the past year, Michigan Medicine and Synthetaic have been collaborating to generate synthetic data to improve the rate at which brain tumors get accurately diagnosed intraoperatively. The initiative involves using a generative adversarial network to “grow" data since large public repositories do not contain the kind of images needed to guide real-time decision-making about which surgery is best for patients.

    May 27, 2021
  • Diagnostic Host Response Tests Digging Deeper For Answers

    Diagnostics World News | Today the term “presymptomatic” is thrown into casual conversations around the dinner table, and large diagnostic companies are interested in producing products providing presymptomatic notice of infection with a pathogen. In fact, new host response bacterial-viral (HR-B/V) tests that could offer an early warning system for infections.

    May 26, 2021
  • Advanced High-End Microbiological Incubators: Protecting Test Samples, Laboratory Personnel and Public Health during the COVID-19 Pandemic

    Diagnostics World News | Diagnostic testing continues to play a vital role in protecting public health throughout the COVID-19 pandemic. However, we should not overlook the importance of using workflows that safeguard the health of medical laboratory personnel by preventing potential exposure to the SARS-CoV-2 virus. This is of utmost significance given the high volume of tests processed every day, increasing the risk to laboratory teams.

    May 24, 2021
  • New Medication Insight Reports for 23andMe+ Members On Depression Drug, Blood Thinner

    Diagnostics World News | 23andMe released two new medication insight reports last week as part of the company’s 23andMe+ membership. The two new reports provide medication insights on how a person’s CYP2C19 metabolizer profile may impact therapies with citalopram, a blood thinner, and clopidogrel, an antidepressant.

    May 20, 2021
  • New Assay Quickly Profiles Patient Immune Response In The Emergency Room

    Diagnostics World News | When patients are battling any kind of infection, the focus is invariably more on the bug in their system than their immune response to its presence. Yet overactivation of the body’s infection-fighting processes is what leads to conditions like sepsis—a leading cause of death in hospitals.

    May 19, 2021
  • Mount Sinai Moving Genomics Into Clinical Care

    Diagnostics World News | The Institute for Genomic Health at Mount Sinai Health System is launching pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that information to bear in clinical decision-making.

    May 18, 2021
  • Era of Personalized Medicine & Therapeutic Drug Monitoring in Autoimmune Diseases

    Diagnostics World News | TNF-α inhibitors have been crucial in many diseases including IBD, psoriasis, cancer, and Alzheimer’s disease, among others. What exactly are we measuring to determine drug effectiveness and how can we, as clinicians, determine if these drugs are improving patient’s symptoms?

    May 13, 2021